These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Effectiveness Associated With BNT162b2 Vaccine Against Emergency Department and Urgent Care Encounters for Delta and Omicron SARS-CoV-2 Infection Among Adolescents Aged 12 to 17 Years. Tartof SY; Frankland TB; Slezak JM; Puzniak L; Hong V; Xie F; Ackerson BK; Valluri SR; Jodar L; McLaughlin JM JAMA Netw Open; 2022 Aug; 5(8):e2225162. PubMed ID: 35921109 [TBL] [Abstract][Full Text] [Related]
25. Protection against symptomatic infection with delta (B.1.617.2) and omicron (B.1.1.529) BA.1 and BA.2 SARS-CoV-2 variants after previous infection and vaccination in adolescents in England, August, 2021-March, 2022: a national, observational, test-negative, case-control study. Powell AA; Kirsebom F; Stowe J; Ramsay ME; Lopez-Bernal J; Andrews N; Ladhani SN Lancet Infect Dis; 2023 Apr; 23(4):435-444. PubMed ID: 36436536 [TBL] [Abstract][Full Text] [Related]
26. Post COVID-19 condition after Wildtype, Delta, and Omicron SARS-CoV-2 infection and prior vaccination: Pooled analysis of two population-based cohorts. Ballouz T; Menges D; Kaufmann M; Amati R; Frei A; von Wyl V; Fehr JS; Albanese E; Puhan MA PLoS One; 2023; 18(2):e0281429. PubMed ID: 36812215 [TBL] [Abstract][Full Text] [Related]
27. Lower prevalence of post-Covid-19 Condition following Omicron SARS-CoV-2 infection. de Bruijn S; van Hoek AJ; Mutubuki EN; Knoop H; Slootweg J; Tulen AD; Franz E; van den Wijngaard CC; van der Maaden T Heliyon; 2024 Apr; 10(7):e28941. PubMed ID: 38617937 [TBL] [Abstract][Full Text] [Related]
28. Clinical Characteristics and Outcomes of Children With SARS-CoV-2 Infection During the Delta and Omicron Variant-Dominant Periods in Korea. Choi SH; Choi JH; Lee JK; Eun BW; Song SH; Ahn B; Kim YK; Yun KW J Korean Med Sci; 2023 Mar; 38(9):e65. PubMed ID: 36880106 [TBL] [Abstract][Full Text] [Related]
29. Factors Associated with Long Covid Symptoms in an Online Cohort Study. Durstenfeld MS; Peluso MJ; Peyser ND; Lin F; Knight SJ; Djibo A; Khatib R; Kitzman H; O'Brien E; Williams N; Isasi C; Kornak J; Carton TW; Olgin JE; Pletcher MJ; Marcus GM; Beatty AL medRxiv; 2022 Dec; ():. PubMed ID: 36523412 [TBL] [Abstract][Full Text] [Related]
30. Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022. Modes ME; Directo MP; Melgar M; Johnson LR; Yang H; Chaudhary P; Bartolini S; Kho N; Noble PW; Isonaka S; Chen P MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(6):217-223. PubMed ID: 35143466 [TBL] [Abstract][Full Text] [Related]
31. Cutaneous manifestations of SARS-CoV-2 infection during the Delta and Omicron waves in 348 691 UK users of the UK ZOE COVID Study app. Visconti A; Murray B; Rossi N; Wolf J; Ourselin S; Spector TD; Freeman EE; Bataille V; Falchi M Br J Dermatol; 2022 Dec; 187(6):900-908. PubMed ID: 35869671 [TBL] [Abstract][Full Text] [Related]
32. Post-Covid-19 condition (Long Covid) in children and young people 12 months after infection or reinfection with the Omicron variant: a prospective observational study. Pinto Pereira SM; Nugawela MD; Stephenson T; Foret-Bruno P; Dalrymple E; Xu L; Whittaker E; Heyman I; Ford T; Segal T; Chalder T; Ladhani SN; Mensah AA; McOwat K; Simmons R; ; Shafran R Sci Rep; 2024 Apr; 14(1):9957. PubMed ID: 38693285 [TBL] [Abstract][Full Text] [Related]
33. 3-year outcomes of discharged survivors of COVID-19 following the SARS-CoV-2 omicron (B.1.1.529) wave in 2022 in China: a longitudinal cohort study. Zhang H; Huang C; Gu X; Wang Y; Li X; Liu M; Wang Q; Xu J; Wang Y; Dai H; Zhang D; Cao B Lancet Respir Med; 2024 Jan; 12(1):55-66. PubMed ID: 38000376 [TBL] [Abstract][Full Text] [Related]
34. Clinical manifestations and long-term symptoms associated with SARS-CoV-2 omicron infection in children aged 0-17 years in Beijing: a single-center study. Li J; Li J; Cao L; Wang L; Chen X; Niu W; Dang L; Dai S; Wang Y; Ge M; Liu W; Song Q; Xu W; Ma L Front Pediatr; 2024; 12():1332020. PubMed ID: 38813546 [TBL] [Abstract][Full Text] [Related]
35. Association between SARS-CoV-2 variants and post COVID-19 condition: findings from a longitudinal cohort study in the Belgian adult population. Thi Khanh HN; Cornelissen L; Castanares-Zapatero D; De Pauw R; Van Cauteren D; Demarest S; Drieskens S; Devleesschauwer B; De Ridder K; Charafeddine R; Smith P BMC Infect Dis; 2023 Nov; 23(1):774. PubMed ID: 37940843 [TBL] [Abstract][Full Text] [Related]
36. SARS-CoV-2 infection in children evaluated in an ambulatory setting during Delta and Omicron time periods. Smith H; Mahon A; Moss A; Rao S J Med Virol; 2023 Jan; 95(1):e28318. PubMed ID: 36397139 [TBL] [Abstract][Full Text] [Related]
37. Comparison of Patients Infected With Delta Versus Omicron COVID-19 Variants Presenting to Paris Emergency Departments : A Retrospective Cohort Study. Bouzid D; Visseaux B; Kassasseya C; Daoud A; Fémy F; Hermand C; Truchot J; Beaune S; Javaud N; Peyrony O; Chauvin A; Vaittinada Ayar P; Bourg A; Riou B; Marot S; Bloom B; Cachanado M; Simon T; Freund Y; Ann Intern Med; 2022 Jun; 175(6):831-837. PubMed ID: 35286147 [TBL] [Abstract][Full Text] [Related]
38. Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants. Accorsi EK; Britton A; Fleming-Dutra KE; Smith ZR; Shang N; Derado G; Miller J; Schrag SJ; Verani JR JAMA; 2022 Feb; 327(7):639-651. PubMed ID: 35060999 [TBL] [Abstract][Full Text] [Related]
39. The diversity in the clinical features of children hospitalized with COVID-19 during the nonvariant, Alpha (B.1.1.7), Delta (B.1.617.2), and Omicron (B.1.1.529) variant periods of SARS CoV-2: Caution for neurological symptoms in Omicron variant. Sahin A; Karadag-Oncel E; Buyuksen O; Ekemen-Keles Y; Ustundag G; Elvan-Tuz A; Tasar S; Didinmez-Taskirdi E; Baykan M; Kara-Aksay A; Yilmaz N; Olgac-Dundar N; Yilmaz D J Med Virol; 2023 Mar; 95(3):e28628. PubMed ID: 36856142 [TBL] [Abstract][Full Text] [Related]
40. The impact of variant and vaccination on SARS-CoV-2 symptomatology; three prospective household cohorts. Westerhof I; de Hoog M; Ieven M; Lammens C; van Beek J; Rozhnova G; Eggink D; Euser S; Wildenbeest J; Duijts L; van Houten M; Goossens H; Giaquinto C; Bruijning-Verhagen P Int J Infect Dis; 2023 Mar; 128():140-147. PubMed ID: 36566773 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]